Jones Financial Companies’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $994K | Buy |
1,908
+413
| +28% | +$215K | ﹤0.01% | 1009 |
|
|
2025
Q1 | $953K | Buy |
1,495
+683
| +84% | +$435K | ﹤0.01% | 883 |
|
|
2024
Q4 | $578K | Buy |
812
+421
| +108% | +$300K | ﹤0.01% | 942 |
|
|
2024
Q3 | $408K | Buy |
391
+234
| +149% | +$244K | ﹤0.01% | 891 |
|
|
2024
Q2 | $165K | Buy |
157
+140
| +824% | +$147K | ﹤0.01% | 889 |
|
|
2024
Q1 | $16.4K | Buy |
+17
| New | +$16.4K | ﹤0.01% | 946 |
|
|
2023
Q1 | – | Sell |
-20
| Closed | -$14K | – | 742 |
|
|
2022
Q4 | $14K | Buy |
+20
| New | +$14K | ﹤0.01% | 453 |
|